liquid biopsy
Definition
A non-invasive diagnostic technique that analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, or cell-free DNA (cfDNA) from blood or other body fluids. Liquid biopsies enable real-time cancer monitoring, treatment resistance detection, and minimal residual disease assessment without invasive tissue biopsies.
In Practice
liquid biopsy is widely used in clinical & diagnostics and related fields. Key applications include:
- Research and experimental design in molecular biology laboratories
- Clinical diagnostics and therapeutic development pipelines
- Automated validation within VigyanLLM's 24-step primer design and analysis framework
Frequently Asked Questions
What is liquid biopsy?
Liquid biopsy analyzes circulating tumor DNA, tumor cells, exosomes, or cell-free DNA from blood for non-invasive cancer monitoring, resistance detection, and minimal residual disease assessment. Explore the full definition and applications on this page.
How does liquid biopsy relate to biomarker?
liquid biopsy is closely connected to biomarker and other Clinical & Diagnostics concepts. Understanding these relationships is essential for comprehensive knowledge in molecular biology and bioinformatics.
How does VigyanLLM use liquid biopsy in its pipeline?
VigyanLLM's 24-step validated pipeline incorporates liquid biopsy as part of its rigorous quality control framework. The platform automates checks related to liquid biopsy to ensure primer design accuracy, specificity, and reliability for research and clinical applications.
VigyanLLM Application
VigyanLLM's validated pipeline addresses biomarker and liquid biopsy through automated computational checks. Explore how the platform handles liquid biopsy across its 24-step framework: